Patents Assigned to NANJING BIOTICA PHARMACEUTICAL COMPANY
  • ORAL APPLICATION OF THIOPEPTCIN
    Publication number: 20190231844
    Abstract: Provided in the present invention are a new use of thiopeptin in the preparation of drugs for treating diseases caused by clostridium difficileinfections and complications thereof, and pharmaceutical preparations containing the thiopeptin for treating diseases caused by clostridium difficileinfections and complications thereof.
    Type: Application
    Filed: November 28, 2016
    Publication date: August 1, 2019
    Applicant: NANJING BIOTICA PHARMACEUTICAL COMPANY
    Inventors: Yijun CHEN, Junjian QIAN, Xuri WU
  • Stable nocathiacin lyophilized injection agent
    Patent number: 9616125
    Abstract: A stable and lyophilized pharmaceutical agent containing nocathiacin, which is prepared by lyophilizing a liquid formulation of nocathiacin, a stabilizer, an excipient, a pH regulator and injectable water, wherein the stabilizer is selected from polyethylene glycol, polysorbate or a mixture thereof, and the pH value of the liquid formulation is 1.0-6.0 is provided.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: April 11, 2017
    Assignee: NANJING BIOTICA PHARMACEUTICAL COMPANY
    Inventor: Yijun Chen